Zev Rosenwaks

Cornell University

Papers

4

Total Citations

27

H-Index

4

About

Zev Rosenwaks is a pioneering figure in reproductive endocrinology and infertility, whose work bridges clinical practice and cutting-edge microfluidic technology. His research centers on optimizing assisted reproductive technologies (ART), with major contributions to embryo selection methodologies and the automation of delicate embryology procedures. Rosenwaks critically evaluated preimplantation genetic testing for aneuploidy (PGT-A), questioning its clinical benefit in a 2018 paper that has garnered 13 citations, sparking essential debate in the field. He has also advanced lab-on-a-chip innovations, including an automated oocyte denudation microfluidic device (2020, 5 citations) and a contact-free ultrasonic microfluidic system for cumulus-oocyte-complex processing (2021, 4 citations), aiming to reduce mechanical stress and temperature fluctuations during ICSI preparation. Beyond technical achievements, Rosenwaks has addressed structural issues in reproductive endocrinology fellowship programs, advocating for tailored training pathways (2021, 5 citations). With a career defined by both rigorous scientific inquiry and practical tool development, his work continues to shape how clinicians approach embryo selection and laboratory automation, making him a key voice in the evolution of fertility treatment.

Research Focus

Key Achievements

4
H-Index
4
Papers
27
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Is preimplantation genetic testing for aneuploidy an essential tool for embryo selection or a costly ‘add-on’ of no clinical benefit?
13 citations · 2018
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Cornell University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago